Computational Biomarker Predicts Chemotherapy Response from Routine Biopsy Images
Phase II TBCRC-030 Trial Demonstrates Image-Based Prediction of Residual Cancer Burden in Early-Stage TNBC A recent analysis from the…
This category contains stories about diagnostic science, tools and technology.
Phase II TBCRC-030 Trial Demonstrates Image-Based Prediction of Residual Cancer Burden in Early-Stage TNBC A recent analysis from the…
National poll finds access barriers and wait times driving interest in virtual dermatology care Nov. 18, 2025 — Miiskin…
The Innovation and Value Initiative (IVI), a non-profit research organization committed to advancing the science, practice, and use of health…